Research on semaglutide and tirzepatide withdrawal has reinforced an important reality: when treatment stops, some patients regain weight and may lose some of the cardiometabolic improvements they gained during treatment
The STAT3-MYC axis promotes survival of leukemia stem cells by regulating SLC1A5 and oxidative phosphorylation
DEGs were identified using the DESeq2 R package, and results were visualized as a volcano plot using the ggplot2 R package ( Metabolic genes were defined based on a curated list 6,40
Analysts project revenue could reach $94B by 2027, but pricing pressure and competition from Novo Nordisk are real risks
Shima Hadidchi, MD, focuses on creating personalized treatment plans tailored to each individuals unique health profile, ensuring safe, steady, and sustainable results